Reuters logo
BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab
September 28, 2017 / 11:12 AM / 3 months ago

BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab

Sept 28 (Reuters) - Galena Biopharma Inc

* Galena Biopharma Inc announces completion of enrollment in two NeuVax™ (nelipepimut-s) clinical trials in combination with Trastuzumab

* Galena Biopharma Inc - ‍look forward to interim results next year for phase 2b trial and primary endpoints for both trials in 2019​

* Galena Biopharma Inc - ‍recommendation from dsmb was to continue her2 3+ trial unmodified​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below